-
FTC Clears AbbVie’s Acquisition of Allergan
contractpharma
May 07, 2020
Only one Allergan director will join the AbbVie board after close.
-
Alexion to buy biopharmaceutical firm Portola in $1.41bn deal
pharmaceutical-business-review
May 06, 2020
Alexion Pharmaceuticals has signed an agreement to acquire commercial-stage biopharmaceutical company Portola in a deal valued at around $1.41bn.
-
Menarini Group to buy Stemline Therapeutics in deal valued at $677m
pharmaceutical-technology
May 06, 2020
Italian pharmaceutical and diagnostics company Menarini Group has signed a definitive agreement to acquire US-based Stemline Therapeutics for up to $677m.
-
US regulators permit AbbVie/Allergan merger
pharmatimes
May 06, 2020
AbbVie's plans to acquire Allergan have been cleared by the US Federal Trade Commission (FTC).
-
Sartorius Completes $825M Acquisition of Danaher Businesses
contractpharma
May 04, 2020
Expands market position in bioanalytics and key areas of the manufacture of biopharmaceuticals.
-
Supernus Acquires US WorldMeds’ CNS Portfolio
contractpharma
April 30, 2020
Adds three marketed products in the U.S. and a product candidate in late-stage development.
-
TSG Announces Acquisition of TrueCoach
prnasia
April 27, 2020
TSG, an Advent portfolio company and leading global provider of business management software, integrated payments, and value-added services to the Health and Fitness, Childcare and Early Education, and Boutique markets, today announced that it has acquire
-
Diamond Pharma Services Acquires PharmaCentral
contractpharma
April 23, 2020
Diamond Pharma Services, a regulatory affairs consulting group has acquired PharmaCentral, a pharmacovigilance services and medical affairs business based in Dublin, Ireland.
-
AskBio Acquires BrainVectis
contractpharma
April 23, 2020
Expands clinical pipeline for neurodegenerative diseases with Huntington’s disease gene therapy candidate.
-
Novartis expands ophthalmology pipeline with Amblyotech acquisition
pharmaceutical-technology
April 21, 2020
Novartis has acquired US-based software startup Amblyotech, which is developing a digital treatment for amblyopia (lazy eye) that leads to vision loss in children and young adults.